Morphine for management of refractory dyspnoea: opiates should be used with caution.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

4 citing papers in PubMed.

1. Using laboratory models to test treatment: morphine reduces dyspnea and hypercapnic ventilatory response.American journal of respiratory and critical care medicine · 2011
   Trial
2. 8-OH-DPAT abolishes the pulmonary C-fiber-mediated apneic response to fentanyl largely via acting on 5HT1A receptors in the nucleus tractus solitarius.American journal of physiology. Regulatory, integrative and comparative physiology · 2012
   Article
3. Management of dyspnea in patients with chronic obstructive pulmonary disease.Wiener medizinische Wochenschrift (1946) · 2009
   Review
4. End of life care in chronic obstructive pulmonary disease: in search of a good death.International journal of chronic obstructive pulmonary disease · 2008
   Review

Corrections and comments

• Comment on
  Randomised, double blind, placebo controlled crossover trial of sustained release morphine for the management of refractory dyspnoea.2003

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as